Search research articles
Contact Us
Filters
Showing results (391-400 of 547) with videos related to
Page
of 55
Sort By:
Molecular Oncology
|
June 10, 2026
Loss of proton-sensing TDAG8 increases tumor progression in mouse models of colon cancer
Ermanno Malagola, Yasmine Illi, Anna Bircher, et al.
Inflammatory Bowel Diseases
|
August 9, 2020
Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program
Gary R Lichtenstein, Gerhard Rogler, Matthew A Ciorba, et al.
Inflammatory Bowel Diseases
|
December 17, 2009
Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: results of the FACTS survey
Alain M Schoepfer, Stephan R Vavricka, Janek Binek, et al.
Plos One
|
August 14, 2014
Hemoglobin and hematocrit levels in the prediction of complicated Crohn's disease behavior--a cohort study
Florian Rieder, Gisela Paul, Elisabeth Schnoy, et al.
Scientific Reports
|
January 31, 2020
Activation of pH-Sensing Receptor OGR1 (GPR68) Induces ER Stress Via the IRE1α/JNK Pathway in an Intestinal Epithelial Cell Model
Chiaki Maeyashiki, Hassan Melhem, Larissa Hering, et al.
Gastrointestinal Endoscopy
|
February 18, 2021
Evaluating key characteristics of ideal colorectal cancer screening modalities: the microsimulation approach
Ansgar Deibel, Lu Deng, Chih-Yuan Cheng, et al.
The Journal of Biological Chemistry
|
June 16, 2011
BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells
Martin Hausmann, Katharina Leucht, Christian Ploner, et al.
Plos One
|
October 13, 2017
Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases
Stefania Fagagnini, Henriette Heinrich, Jean-Benoît Rossel, et al.
The American Journal of Gastroenterology
|
June 5, 2013
CYP3A4-catalyzed simvastatin metabolism as a non-invasive marker of small intestinal health in celiac disease
Belén Morón, Anil K Verma, Prasenjit Das, et al.
BMC Genomics
|
September 11, 2016
Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening
Michael K Kiessling, Sven Schuierer, Silke Stertz, et al.
Page
of 55
Search research articles
Search
Showing results (391-400 of 547) with videos related to
Sort By:
Page
of 55
Molecular Oncology
|
June 10, 2026
Loss of proton-sensing TDAG8 increases tumor progression in mouse models of colon cancer
Ermanno Malagola, Yasmine Illi, Anna Bircher, et al.
Inflammatory Bowel Diseases
|
August 9, 2020
Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program
Gary R Lichtenstein, Gerhard Rogler, Matthew A Ciorba, et al.
Inflammatory Bowel Diseases
|
December 17, 2009
Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: results of the FACTS survey
Alain M Schoepfer, Stephan R Vavricka, Janek Binek, et al.
Plos One
|
August 14, 2014
Hemoglobin and hematocrit levels in the prediction of complicated Crohn's disease behavior--a cohort study
Florian Rieder, Gisela Paul, Elisabeth Schnoy, et al.
Scientific Reports
|
January 31, 2020
Activation of pH-Sensing Receptor OGR1 (GPR68) Induces ER Stress Via the IRE1α/JNK Pathway in an Intestinal Epithelial Cell Model
Chiaki Maeyashiki, Hassan Melhem, Larissa Hering, et al.
Gastrointestinal Endoscopy
|
February 18, 2021
Evaluating key characteristics of ideal colorectal cancer screening modalities: the microsimulation approach
Ansgar Deibel, Lu Deng, Chih-Yuan Cheng, et al.
The Journal of Biological Chemistry
|
June 16, 2011
BCL-2 modifying factor (BMF) is a central regulator of anoikis in human intestinal epithelial cells
Martin Hausmann, Katharina Leucht, Christian Ploner, et al.
Plos One
|
October 13, 2017
Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases
Stefania Fagagnini, Henriette Heinrich, Jean-Benoît Rossel, et al.
The American Journal of Gastroenterology
|
June 5, 2013
CYP3A4-catalyzed simvastatin metabolism as a non-invasive marker of small intestinal health in celiac disease
Belén Morón, Anil K Verma, Prasenjit Das, et al.
BMC Genomics
|
September 11, 2016
Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening
Michael K Kiessling, Sven Schuierer, Silke Stertz, et al.
Page
of 55